Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 72,069 shares of Dolby Laboratories stock in a transaction on Monday, July 15th. The shares were sold at an average price of $65.10, for a total transaction of $4,691,691.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Wednesday, July 17th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.27, for a total transaction of $6,527,000.00.
  • On Friday, July 12th, Dagmar Dolby sold 22,069 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.02, for a total transaction of $1,434,926.38.
  • On Friday, July 5th, Dagmar Dolby sold 26,358 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.01, for a total transaction of $1,713,533.58.
  • On Wednesday, July 3rd, Dagmar Dolby sold 77,692 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.17, for a total transaction of $5,063,187.64.
  • On Monday, July 1st, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.06, for a total transaction of $3,253,000.00.
  • On Thursday, June 27th, Dagmar Dolby sold 51,777 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.06, for a total transaction of $3,368,611.62.
  • On Tuesday, June 25th, Dagmar Dolby sold 15,617 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.04, for a total transaction of $1,015,729.68.
  • On Friday, June 21st, Dagmar Dolby sold 93,113 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.11, for a total transaction of $6,062,587.43.
  • On Wednesday, May 15th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.05, for a total transaction of $3,252,500.00.
  • On Wednesday, May 8th, Dagmar Dolby sold 46,781 shares of Dolby Laboratories stock. The stock was sold at an average price of $65.12, for a total transaction of $3,046,378.72.

Shares of DLB stock opened at $65.11 on Friday. The firm has a fifty day simple moving average of $63.87. Dolby Laboratories, Inc. has a 52-week low of $58.17 and a 52-week high of $72.04. The firm has a market cap of $6.64 billion, a PE ratio of 27.13, a price-to-earnings-growth ratio of 2.11 and a beta of 0.82.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings data on Wednesday, May 1st. The electronics maker reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.18. Dolby Laboratories had a net margin of 24.93% and a return on equity of 11.12%. The firm had revenue of $338.26 million for the quarter, compared to analyst estimates of $337.45 million. During the same quarter in the prior year, the firm earned $0.73 EPS. The company’s revenue was up 12.9% on a year-over-year basis. On average, equities research analysts expect that Dolby Laboratories, Inc. will post 2.38 earnings per share for the current fiscal year.

A number of research firms recently commented on DLB. Zacks Investment Research downgraded shares of Inflarx from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. B. Riley set a $18.00 price objective on shares of TiVo and gave the company a “buy” rating in a research report on Thursday, June 13th. Finally, ValuEngine raised shares of Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Monday, April 1st. Two analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Dolby Laboratories presently has a consensus rating of “Buy” and an average target price of $76.50.

Several large investors have recently made changes to their positions in DLB. Fox Run Management L.L.C. acquired a new position in Dolby Laboratories in the second quarter valued at about $754,000. Unigestion Holding SA boosted its holdings in Dolby Laboratories by 54.2% in the second quarter. Unigestion Holding SA now owns 77,514 shares of the electronics maker’s stock valued at $5,007,000 after acquiring an additional 27,259 shares during the last quarter. Marathon Asset Management LLP boosted its holdings in Dolby Laboratories by 7.7% in the second quarter. Marathon Asset Management LLP now owns 684,400 shares of the electronics maker’s stock valued at $44,209,000 after acquiring an additional 48,850 shares during the last quarter. PFS Investments Inc. bought a new stake in Dolby Laboratories in the second quarter valued at approximately $336,000. Finally, Boston Private Wealth LLC bought a new position in shares of Dolby Laboratories during the 2nd quarter worth approximately $649,000. Institutional investors and hedge funds own 56.00% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones.

Further Reading: How to track put option volume

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.